Epichem delivers high quality medicinal and synthetic chemistry
services for drug discovery projects from hit assessment through to candidate nomination. We have a successful proven track record in delivering project milestones and this includes working with customers that are keen on a high impact, low maintenance team.
We have made significant contributions to new compounds in pre-clinical and clinical trials and have experience in a broad range of disease indications including central nervous system disorders, oncology, HIV, Hepatitis C, age related, and infectious diseases.
Early-phase drug discovery
Our early-phase drug discovery expertise includes:
Synthesis services to support research & development
Our custom synthesis capability adds significant value to R&D outcomes. Our services include:
Ready to talk?
If you’ve got a new discovery program in the pipeline—or need chemistry support for an ongoing one—we’d love to hear from you.
📬 Get in touch at sales@epichem.com or fill out our contact form here and let’s explore how we can support your next step.
Grant-funded drug discovery projects
Epichem regularly supports universities, startups and research institutes undertaking grant-funded therapeutics and translational R&D programs. Learn more about MRFF funding, NHMRC grants, CRC-P opportunities and other drug discovery funding pathways where Epichem may support medicinal chemistry activities.
Want to learn more?
Interested in learning about which factors to consider when choosing a CRO?
Why not check out our Blog post:
Choosing the Right CRO for Medicinal Chemistry: What Really Matters